Paola Guglielmelli, MD, PhD1,2*, Giada Rotunno1,2*, Annalisa Pacilli, PhD1,2*, Elisa Rumi, MD3*, Vittorio Rosti, MD4, Federica Delaini, MD5*, Margherita Maffioli, MD6*, Tiziana Fanelli, MSc2*, Alessandro Pancrazzi, BS1,2*, Lisa Pieri, MD, PhD1,7*, Raimonda Fjerza, MD1,2*, Daniela Pietra, PhD3*, Daniela Cilloni, MD8, Francesco Passamonti9*, Alessandro Rambaldi, MD10, Giovanni Barosi, MD4, Tiziano Barbui, MD11*, Mario Cazzola, MD12 and Alessandro M. Vannucchi, MD1,13
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
3Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
5Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
6Division of Hematology, Ospedale di Circolo - Fondazione Macchi Università degli Studi dell'Insubria, Varese, Italy
7Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy
8Dept Hematology and Clinical and Biological Sciences, University of Turin, S Luigi Hospital, Turin, Italy
9Ospedale di Circolo e Fondazione Macchi, Varese, Italy
10Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
11Hospital Papa Giovanni XXIII and Research Foundation, Bergamo, Italy
12Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
13University of Florence, Florence, Italy